Back to News
Market Impact: 0.4

Chocolate makers get Halloween fright as health-conscious US shoppers cut back

Source: Investing.com

Consumer Demand & RetailCorporate EarningsCorporate Guidance & OutlookCommodities & Raw MaterialsM&A & RestructuringHealthcare & Biotech
Chocolate makers get Halloween fright as health-conscious US shoppers cut back

U.S. Halloween chocolate sales fell $33.1 million in the nine weeks through October 17 versus a year earlier, the largest drop in at least three years, as cost pressures and demand for smaller, lower-sugar snacks weigh on traditional candy. Hershey lowered its organic net sales growth target for the year, while Mondelez reported flat North American volumes and a 1.6% price increase in Q3; cocoa has fallen to under $3,000 per metric ton from a 2024 record of $12,000. Mondelez said lower cocoa costs are beginning to benefit results and announced it would acquire Undercover Snacks.

Analysis

The key earnings risk is not cocoa alone, but whether lower input costs are passed through as lower shelf prices before they revive unit demand. If brands discount to defend volume, near-term gross-margin relief may be competed away; if they hold price, smaller packs and substitution toward non-chocolate snacks can persist. Procurement and inventory timing will determine when falling cocoa reaches reported margins, so futures prices are not a near-term earnings proxy.

Relative positioning favors MDLZ over HSY, but not as an unhedged sector call: MDLZ has shown better recent volume momentum and is adding a better-for-you adjacency, while HSY has reduced its sales outlook into a highly seasonal demand window. The Undercover Snacks acquisition is strategic optionality, not yet evidence of a material earnings offset; deal economics and integration remain unverified. Health-oriented substitution also benefits non-chocolate alternatives and potentially private-label offerings, while pressuring traditional, larger-format candy. The GLP-1 link is a plausible long-run headwind, not yet a quantified demand forecast.

Over days, Halloween sell-through can move sentiment but is a noisy, seasonal signal. Over 1–3 months, watch whether cocoa relief translates into shelf-price moderation and sustained volumes. Over 6–18 months, the test is whether reformulations and smaller packs retain consumers without diluting brand value. Contrarian risk: pessimism may be overextended if lower prices restore impulse purchases; conversely, commodity relief may be mistaken for durable margin expansion. Thesis weakens if HSY restores its outlook and category volumes stabilize, or if MDLZ North American volumes deteriorate. Verify company-specific cocoa cost lags, brand/format mix, and acquisition terms before sizing.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly negative

Sentiment Score

-0.25

Ticker Sentiment

HSY-0.45
MDLZ-0.20

Key Decisions for Investors

  • Consider a modest, valuation-checked long MDLZ / short HSY relative-value position rather than a broad chocolate short. Reassess after the next results: require MDLZ volume momentum to hold and HSY guidance or sell-through to remain weaker; avoid adding solely on this seasonal data point.
  • For the next 1–3 months, monitor realized shelf prices, unit volumes, and gross-margin commentary—not cocoa futures alone. A price-led volume recovery with stable margins supports the pair; discounting that fails to lift units argues against it.
  • Treat MDLZ’s Undercover Snacks deal as a watch item, not an earnings catalyst until purchase economics, scale, and distribution plans are disclosed. Track whether healthier/smaller formats gain share without cannibalizing core products.
  • Falsifiers: HSY restores its sales outlook or reports improving demand, MDLZ North American volumes weaken, or cocoa costs reverse upward before lower costs flow through. Check relative valuation and current positioning before initiating; neither is supplied here.

More News

From AllMind Research

Browse all research